Granules India gets nod to raise Rs 500 crore via QIP

14 Jun 2017 Evaluate

Granules India has received its shareholders’ approval to go ahead with the proposed Rs 500 crore share sales to investors. The company which held its extra ordinary general meeting in Hyderabad has passed a special resolution enabling the management to sell shares to raise Rs 500 crore in a qualified institution placement (QIP).

The proposed capital raise will help the company to meet the capital expenditure requirements for the ongoing and future projects of the company and its subsidiaries, working capital requirements, investment in subsidiary companies, repayment of rupee term loans, general corporate purposes including pursuing new business opportunities and meeting the issue expenses.

Granules India, the Hyderabad-head quartered company, manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. It intends to increase its global presence with a firm base and operations in the US.

Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.